166 related articles for article (PubMed ID: 35462409)
1. Risk of radiculopathy caused by second course of spine stereotactic body radiotherapy.
Ito K; Nakajima Y; Ogawa H; Taguchi K; Sugita S
Jpn J Clin Oncol; 2022 Aug; 52(8):911-916. PubMed ID: 35462409
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and toxicity of re-irradiation spine stereotactic body radiotherapy with respect to irradiation dose history.
Ito K; Ogawa H; Nakajima Y
Jpn J Clin Oncol; 2021 Feb; 51(2):264-270. PubMed ID: 33020807
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic Body Radiotherapy for Spinal Metastases: Clinical Experience in 134 Cases From a Single Japanese Institution.
Ito K; Ogawa H; Shimizuguchi T; Nihei K; Furuya T; Tanaka H; Karasawa K
Technol Cancer Res Treat; 2018 Jan; 17():1533033818806472. PubMed ID: 30355246
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of different fractions in stereotactic body radiotherapy for spinal metastases: A systematic review.
Gong Y; Xu L; Zhuang H; Jiang L; Wei F; Liu Z; Li Y; Yu M; Ni K; Liu X
Cancer Med; 2019 Oct; 8(14):6176-6184. PubMed ID: 31489788
[TBL] [Abstract][Full Text] [Related]
5. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.
Hashmi A; Guckenberger M; Kersh R; Gerszten PC; Mantel F; Grills IS; Flickinger JC; Shin JH; Fahim DK; Winey B; Oh K; John Cho BC; Létourneau D; Sheehan J; Sahgal A
J Neurosurg Spine; 2016 Nov; 25(5):646-653. PubMed ID: 27341054
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic body radiotherapy for spine metastases: a review of 24 Gy in 2 daily fractions.
Nguyen EK; Ruschin M; Zhang B; Soliman H; Myrehaug S; Detsky J; Chen H; Sahgal A; Tseng CL
J Neurooncol; 2023 May; 163(1):15-27. PubMed ID: 37155133
[TBL] [Abstract][Full Text] [Related]
7. Vertebral compression fractures after stereotactic body radiation therapy: a large, multi-institutional, multinational evaluation.
Jawad MS; Fahim DK; Gerszten PC; Flickinger JC; Sahgal A; Grills IS; Sheehan J; Kersh R; Shin J; Oh K; Mantel F; Guckenberger M;
J Neurosurg Spine; 2016 Jun; 24(6):928-36. PubMed ID: 26895526
[TBL] [Abstract][Full Text] [Related]
8. Re-irradiation spine stereotactic body radiotherapy following high-dose conventional radiotherapy for metastatic epidural spinal cord compression: a retrospective study.
Koide Y; Haimoto S; Shimizu H; Aoyama T; Kitagawa T; Shindo Y; Nagai N; Hashimoto S; Tachibana H; Kodaira T
Jpn J Radiol; 2024 Jun; 42(6):662-672. PubMed ID: 38413551
[TBL] [Abstract][Full Text] [Related]
9. Salvage Stereotactic Body Radiotherapy (SBRT) Following In-Field Failure of Initial SBRT for Spinal Metastases.
Thibault I; Campbell M; Tseng CL; Atenafu EG; Letourneau D; Yu E; Cho BC; Lee YK; Fehlings MG; Sahgal A
Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):353-60. PubMed ID: 26383680
[TBL] [Abstract][Full Text] [Related]
10. Postoperative re-irradiation using stereotactic body radiotherapy for metastatic epidural spinal cord compression.
Ito K; Nihei K; Shimizuguchi T; Ogawa H; Furuya T; Sugita S; Hozumi T; ; Karasawa K
J Neurosurg Spine; 2018 Sep; 29(3):332-338. PubMed ID: 29905524
[TBL] [Abstract][Full Text] [Related]
11. A prospective multicentre feasibility study of stereotactic body radiotherapy in Japanese patients with spinal metastases.
Ito K; Furuya T; Shikama N; Nihei K; Tanaka H; Kumazaki Y; Nishimura H; Karasawa K
Jpn J Clin Oncol; 2019 Dec; 49(11):999-1003. PubMed ID: 31665478
[TBL] [Abstract][Full Text] [Related]
12. Dose-intensified hypofractionated stereotactic body radiation therapy for painful spinal metastases: Results of a phase 2 study.
Guckenberger M; Sweeney RA; Hawkins M; Belderbos J; Andratschke N; Ahmed M; Madani I; Mantel F; Steigerwald S; Flentje M
Cancer; 2018 May; 124(9):2001-2009. PubMed ID: 29499073
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic body radiotherapy for bone metastases in patients with colorectal cancer.
Ito K; Yamaguchi T; Ogawa H; Nakajima Y; Karasawa K
Jpn J Clin Oncol; 2020 Dec; 50(12):1442-1446. PubMed ID: 32719860
[TBL] [Abstract][Full Text] [Related]
14. Phase 2 Clinical Trial of Separation Surgery Followed by Stereotactic Body Radiation Therapy for Metastatic Epidural Spinal Cord Compression.
Ito K; Sugita S; Nakajima Y; Furuya T; Hiroaki O; Hayakawa S; Hozumi T; Saito M; Karasawa K
Int J Radiat Oncol Biol Phys; 2022 Jan; 112(1):106-113. PubMed ID: 34715257
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic Body Radiotherapy (SBRT) for Spinal Metastases: Who Will Benefit the Most from SBRT?
Park HJ; Kim HJ; Won JH; Lee SC; Chang AR
Technol Cancer Res Treat; 2015 Apr; 14(2):159-67. PubMed ID: 24502552
[TBL] [Abstract][Full Text] [Related]
16. Mature Imaging-Based Outcomes Supporting Local Control for Complex Reirradiation Salvage Spine Stereotactic Body Radiotherapy.
Detsky JS; Nguyen TK; Lee Y; Atenafu E; Maralani P; Husain Z; Tseng CL; Myrehaug S; Soliman H; Sahgal A
Neurosurgery; 2020 Sep; 87(4):816-822. PubMed ID: 32374852
[TBL] [Abstract][Full Text] [Related]
17. Intensity-modulated stereotactic radiotherapy of paraspinal tumors: a preliminary report.
Bilsky MH; Yamada Y; Yenice KM; Lovelock M; Hunt M; Gutin PH; Leibel SA
Neurosurgery; 2004 Apr; 54(4):823-30; discussion 830-1. PubMed ID: 15046647
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Outcomes After Stereotactic Radiosurgery for Spine Metastases: Radiation Dose-Response for Late Toxicity.
Ling DC; Flickinger JC; Burton SA; Heron DE; Quinn AE; Bejjani GK; Engh JA; Gerszten PC; Amankulor NM; Vargo JA
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):602-609. PubMed ID: 29678526
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost in Patients With Spinal Metastases.
Pontoriero A; Iatì G; Cacciola A; Conti A; Brogna A; Siragusa C; Ferini G; Davì V; Tamburella C; Molino L; Cambareri D; Severo C; Parisi S; Settineri N; Ielo I; Pergolizzi S
Technol Cancer Res Treat; 2020; 19():1533033820904447. PubMed ID: 32336255
[TBL] [Abstract][Full Text] [Related]
20. Fracture risk following stereotactic body radiotherapy for long bone metastases.
Ito K; Nakajima Y; Ogawa H; Taguchi K
Jpn J Clin Oncol; 2022 Jan; 52(1):47-52. PubMed ID: 34648002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]